LIMK1
TYR version of PSPA with Y as phospho-acceptor
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| A6NMY6 | Y333 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| O00410 | S974 | Sugiyama | IPO5 KPNB3 RANBP5 | VIQSADSKTKENVNAtENCIsAVGKIMKFKPDCVNVEEVLP |
| O14579 | Y304 | Sugiyama | COPE | HPFIKEYQAKENDFDRLVLQyAPsA________________ |
| O14744 | Y502 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | NEVRACREKDRDPEAQFEMPyVVRLHNFHQLSAPQPCFTFS |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O15357 | Y190 | Sugiyama | INPPL1 SHIP2 | AAESAPNGLSTVSHDYLKGsyGLDLEAVRGGASHLPHLTRT |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15460 | Y249 | Sugiyama | P4HA2 UNQ290/PRO330 | LTRRLLSLDPSHERAGGNLRyFEQLLEEEREKTLTNQTEAE |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43448 | Y311 | Sugiyama | KCNAB3 KCNA3B | LITSKYDGRVPDTCRASIKGyQWLKDKVQSEDGKKQQAKVM |
| O43707 | Y397 | Sugiyama | ACTN4 | GKMVSDINNGWQHLEQAEKGyEEWLLNEIRRLERLDHLAEK |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43765 | Y141 | Sugiyama | SGTA SGT SGT1 | NPANAVYFCNRAAAYSKLGNyAGAVQDCERAICIDPAySKA |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O75369 | T907 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTYGGD |
| O75390 | Y345 | Sugiyama | CS | DEKLRDYIWNtLNSGRVVPGyGHAVLRKTDPRYTCQREFAL |
| O75475 | Y18 | Sugiyama | PSIP1 DFS70 LEDGF PSIP2 | ___MTRDFKPGDLIFAKMKGyPHWPARVDEVPDGAVKPPTN |
| O75534 | S766 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | AAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDNsMGFG |
| O75683 | Y10 | Sugiyama | SURF6 SURF-6 | ___________MASLLAKDAyLQsLAKKICSHsAPEQQART |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y172 | Sugiyama | LDHA PIG19 | GFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHGWVLGE |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00505 | Y179 | Sugiyama | GOT2 KYAT4 | KPTWGNHtPIFRDAGMQLQGyRYYDPKtCGFDFtGAVEDIS |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05787 | Y282 | Sugiyama | KRT8 CYK8 | EVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRR |
| P06730 | Y197 | Sugiyama | EIF4E EIF4EL1 EIF4F | THIGRVYKERLGLPPKIVIGyQsHADTAtKsGsttKNRFVV |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S419 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | CRSERLAKyNQLLRIEEELGsKAKFAGRNFRNPLAK_____ |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y257 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | TDKVVIGMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLA |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y407 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GLCtGQIKTGAPCRSERLAKyNQLLRIEEELGsKAKFAGRN |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | Y351 | Sugiyama | GPI | FGCETHAMLPYDQYLHRFAAyFQQGDMEsNGKYITKSGtRV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y327 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LKKEECPAVRLITLEEEMTKyKPEsEELtAERItEFCHRFL |
| P07237 | Y457 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | VHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESGGQDG |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y333 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07737 | S58 | Sugiyama | PFN1 | KtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsL |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07858 | Y215 | Sugiyama | CTSB CPSB | RPPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNS |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y466 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKE |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07900 | Y627 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIEtLR |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08758 | Y94 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | TGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLtEII |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DPH7 | T223 | Sugiyama | TUBA3C TUBA2 | MVDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLR |
| P10412 | Y71 | Sugiyama | H1-4 H1F4 HIST1H1E | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S329 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | LFRGtLDPVEKALRDAKLDKsQIHDIVLVGGstRIPKIQKL |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | Y134 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FYPEEVSSMVLTKMKEIAEAyLGKtVTNAVVtVPAyFNDsQ |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y382 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | PLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINPYQP |
| P12814 | Y193 | Sugiyama | ACTN1 | WKDGLGFCALIHRHRPELIDyGKLRKDDPLTNLNTAFDVAE |
| P12814 | Y378 | Sugiyama | ACTN1 | GRMVSDINNAWGCLEQVEKGyEEWLLNEIRRLERLDHLAEK |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P12956 | Y534 | Sugiyama | XRCC6 G22P1 | MNKRLGsLVDEFKELVyPPDyNPEGKVtKRKHDNEGSGSKR |
| P13010 | Y316 | Sugiyama | XRCC5 G22P2 | CLNDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y252 | Sugiyama | PDIA4 ERP70 ERP72 | LAKVDAtAETDLAKRFDVsGyPTLKIFRKGRPYDYNGPREK |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13796 | Y462 | Sugiyama | LCP1 PLS2 | VNKPPYPKLGGNMKKLENCNyAVELGKNQAKFsLVGIGGQD |
| P13797 | Y465 | Sugiyama | PLS3 | VNKPPYPKLGANMKKLENCNyAVELGKHPAKFSLVGIGGQD |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S55 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | IDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMNVARLN |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | Y429 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IKLYVRRVFITDDFHDMMPKyLNFVKGVVDsDDLPLNVsRE |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y727 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DKTVLDLAVVLFETATLRsGyLLPDTKAYGDRIERMLRLsL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14735 | Y224 | Sugiyama | IDE | LEKATGNPKHPFSKFGTGNKyTLETRPNQEGIDVRQELLKF |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P16402 | Y72 | Sugiyama | H1-3 H1F3 HIST1H1D | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16403 | Y71 | Sugiyama | H1-2 H1F2 HIST1H1C | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17812 | Y468 | Sugiyama | CTPS1 CTPS | MRLGKRRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVW |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18206 | S820 | Sugiyama | VCL | DAKAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEP |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | Y4 | Sugiyama | RPL17 | _________________MVRysLDPENPtKsCKSRGSNLRV |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P21333 | Y2379 | Sugiyama | FLNA FLN FLN1 | GAKGAIDAKVHsPsGALEECyVtEIDQDKYAVRFIPRENGV |
| P22061 | S132 | Sugiyama | PCMT1 | IKELVDDsVNNVRKDDPTLLssGRVQLVVGDGRMGYAEEAP |
| P22314 | Y451 | Sugiyama | UBA1 A1S9T UBE1 | CLPEDKEVLTEDKCLQRQNRyDGQVAVFGsDLQEKLGKQKY |
| P22314 | Y845 | Sugiyama | UBA1 A1S9T UBE1 | RLEELKATLPsPDKLPGFKMyPIDFEKDDDSNFHMDFIVAA |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22492 | Y75 | Sugiyama | H1-6 H1FT H1T HIST1H1T | SQERVGMSLVALKKALAAAGyDVEKNNSRIKLSLKSLVNKG |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | Y347 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MGGPyGGGNyGPGGsGGsGGyGGRsRy______________ |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23284 | Y133 | Sugiyama | PPIB CYPB | tGGKsIyGERFPDENFKLKHyGPGWVsMANAGKDTNGsQFF |
| P23381 | S357 | Sugiyama | WARS1 IFI53 WARS WRS | STFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAF |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | S3 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CFL1 CFL | __________________MAsGVAVsDGVIKVFNDMKVRKs |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P24752 | Y219 | Sugiyama | ACAT1 ACAT MAT | NTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVt |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P25788 | Y105 | Sugiyama | PSMA3 HC8 PSC8 | ARSLADIAREEAsNFRSNFGyNIPLKHLADRVAMYVHAYTL |
| P26358 | Y991 | Sugiyama | DNMT1 AIM CXXC9 DNMT | EHyRKYSDYIKGSNLDAPEPyRIGRIKEIFCPKKSNGRPNE |
| P26639 | Y575 | Sugiyama | TARS1 TARS | YHQCATIQLDFQLPIRFNLtyVsHDGDDKKRPVIVHRAILG |
| P26885 | Y112 | Sugiyama | FKBP2 FKBP13 | GLLGMCEGEKRKLVIPsELGyGERGAPPKIPGGATLVFEVE |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | S53 | Sugiyama | CALR CRTC | WtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDAR |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27797 | Y57 | Sugiyama | CALR CRTC | WIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDARFyAL |
| P28074 | Y171 | Sugiyama | PSMB5 LMPX MB1 X | GMGLSMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGS |
| P28074 | Y172 | Sugiyama | PSMB5 LMPX MB1 X | MGLSMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSV |
| P29144 | Y118 | Sugiyama | TPP2 | KIPASWTNPSGKYHIGIKNGyDFYPKALKERIQKERKEKIW |
| P29401 | S190 | Sugiyama | TKT | ASIYKLDNLVAILDINRLGQsDPAPLQHQMDIyQKRCEAFG |
| P29401 | S308 | Sugiyama | TKT | PPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQALAKL |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P30041 | Y89 | Sugiyama | PRDX6 AOP2 KIAA0106 | IALSIDSVEDHLAWSKDINAyNCEEPtEKLPFPIIDDRNRE |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30101 | S98 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | VPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGP |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31327 | Y582 | Sugiyama | CPS1 | APsFAVEsIEDALKAADTIGyPVMIRSAyALGGLGsGICPN |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y376 | Sugiyama | STIP1 | NPDLALEEKNKGNECFQKGDyPQAMKHYTEAIKRNPKDAKL |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33993 | Y393 | Sugiyama | MCM7 CDC47 MCM2 | GNINICLMGDPGVAKSQLLsyIDRLAPRSQYTTGRGssGVG |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35609 | Y385 | Sugiyama | ACTN2 | GKMVSDIAGAWQRLEQAEKGyEEWLLNEIRRLERLEHLAEK |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P40227 | S246 | Sugiyama | CCT6A CCT6 CCTZ | EDAyILTCNVSLEYEKTEVNsGFFyKSAEEREKLVKAERKF |
| P40925 | S153 | Sugiyama | MDH1 MDHA | ANtNCLtAsKSAPSIPKENFsCLtRLDHNRAKAQIALKLGV |
| P40926 | Y80 | Sugiyama | MDH2 | HtPGVAADLsHIEtKAAVKGyLGPEQLPDCLKGCDVVVIPA |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P45974 | Y851 | Sugiyama | USP5 ISOT | IYNDQKVCASEKPPKDLGyIyFyQRVAS_____________ |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46776 | S106 | Sugiyama | RPL27A | tRVNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKA |
| P46776 | Y108 | Sugiyama | RPL27A | VNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKAKF |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46940 | Y1478 | Sugiyama | IQGAP1 KIAA0051 | KIQTGLKKLTELGtVDPKNKyQELINDIARDIRNQRRYRQR |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47756 | Y64 | Sugiyama | CAPZB | DQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKyDPPLE |
| P48556 | Y225 | Sugiyama | PSMD8 | VAEFHTELERLPAKDIQTNVyIKHPVSLEQYLMEGSYNKVF |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49327 | S2032 | Sugiyama | FASN FAS | ELDYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEG |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49588 | S188 | Sugiyama | AARS1 AARS | PGNMKDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDD |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50990 | Y173 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | NLRDIDEVssLLRTSIMSKQyGNEVFLAKLIAQACVSIFPD |
| P51858 | Y23 | Sugiyama | HDGF HMG1L2 | RSNRQKEYKCGDLVFAKMKGyPHWPARIDEMPEAAVKstAN |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P53621 | Y579 | Sugiyama | COPA | GIIRTLDLPIyVTRVKGNNVyCLDRECRPRVLtIDPTEFKF |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P53667 | S298 | EPSD|Sugiyama | LIMK1 LIMK | YTPSGEAGSSARQKPVLRsCsIDRsPGAGsLGsPAsQRKDL |
| P53667 | S302 | Sugiyama | LIMK1 LIMK | GEAGSSARQKPVLRsCsIDRsPGAGsLGsPAsQRKDLGRSE |
| P53667 | S307 | Sugiyama | LIMK1 LIMK | SARQKPVLRsCsIDRsPGAGsLGsPAsQRKDLGRSEsLRVV |
| P53667 | S310 | EPSD|Sugiyama | LIMK1 LIMK | QKPVLRsCsIDRsPGAGsLGsPAsQRKDLGRSEsLRVVCRP |
| P53667 | S313 | Sugiyama | LIMK1 LIMK | VLRsCsIDRsPGAGsLGsPAsQRKDLGRSEsLRVVCRPHRI |
| P53667 | Y514 | Sugiyama | LIMK1 LIMK | GLRSLKKPDRKKRYtVVGNPyWMAPEMINGRSYDEKVDVFS |
| P53667 | Y552 | Sugiyama | LIMK1 LIMK | VFSFGIVLCEIIGRVNADPDyLPRTMDFGLNVRGFLDRYCP |
| P53667 | Y632 | Sugiyama | LIMK1 LIMK | AGHLPLGPQLEQLDRGFWETyRRGESGLPAHPEVPD_____ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57721 | S59 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | EGGLNVTLTIRLLMHGKEVGsIIGKKGETVKKMREESGARI |
| P57723 | S31 | Sugiyama | PCBP4 | EPELSITLTLRMLMHGKEVGsIIGKKGETVKRIREQSSARI |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60228 | Y445 | Sugiyama | EIF3E EIF3S6 INT6 | KLNQNSRSEAPNWAtQDsGFy____________________ |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60981 | S3 | EPSD|PSP | DSTN ACTDP DSN | __________________MAsGVQVADEVCRIFYDMKVRKC |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61247 | S203 | Sugiyama | RPS3A FTE1 MFTL | EVVNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKF |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | Y205 | Sugiyama | RPS3A FTE1 MFTL | VNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKFEL |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61313 | Y59 | Sugiyama | RPL15 EC45 TCBAP0781 | APRPTRPDKARRLGYKAKQGyVIyRIRVRRGGRKRPVPKGA |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63172 | Y34 | Sugiyama | DYNLT1 TCTEL1 TCTEX-1 TCTEX1 | VDEVSNIVKEAIESAIGGNAyQHSKVNQWTTNVVEQTLSQL |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P67936 | T237 | Sugiyama | TPM4 | IDDLEEKLAQAKEENVGLHQtLDQtLNELNCI_________ |
| P67936 | T241 | Sugiyama | TPM4 | EEKLAQAKEENVGLHQtLDQtLNELNCI_____________ |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | T223 | Sugiyama | TUBA1B | MVDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLR |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P68366 | T223 | Sugiyama | TUBA4A TUBA1 | MVDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLR |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q02539 | Y74 | Sugiyama | H1-1 H1F1 HIST1H1A | SKERGGVSLAALKKALAAAGyDVEKNNSRIKLGIKsLVsKG |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q04760 | Y115 | Sugiyama | GLO1 | RKATLELTHNWGtEDDEtQsyHNGNsDPRGFGHIGIAVPDV |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | S32 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | APNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVC |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q06830 | Y34 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | NFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVCPT |
| Q07866 | Y474 | Sugiyama | KLC1 KLC KNS2 | KACKVDsPtVTTtLKNLGALyRRQGKFEAAETLEEAAMRSR |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08752 | Y323 | Sugiyama | PPID CYP40 CYPD | DPSNTKALYRRAQGWQGLKEyDQALADLKKAQGIAPEDKAI |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13283 | Y125 | Sugiyama | G3BP1 G3BP | LRRFMQtFVLAPEGsVANKFyVHNDIFRyQDEVFGGFVtEP |
| Q13303 | Y270 | Sugiyama | KCNAB2 KCNA2B KCNK2 | IVSGKYDSGIPPYSRAsLKGyQWLKDKILSEEGRRQQAKLK |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13547 | S88 | Sugiyama | HDAC1 RPD3L1 | HSDDyIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDGLFE |
| Q13573 | Y260 | Sugiyama | SNW1 SKIIP SKIP | KEQQEWKIPPCISNWKNAKGytIPLDKRLAADGRGLQTVHI |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14980 | S1183 | Sugiyama | NUMA1 NMP22 NUMA | ALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQDHS |
| Q15181 | S127 | Sugiyama | PPA1 IOPPP PP | NDKHTGCCGDNDPIDVCEIGsKVCARGEIIGVKVLGILAMI |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15365 | S27 | Sugiyama | PCBP1 | ESGLNVTLTIRLLMHGKEVGsIIGKKGESVKRIREEsGARI |
| Q15366 | S27 | Sugiyama | PCBP2 | EGGLNVTLTIRLLMHGKEVGsIIGKKGESVKKMREESGARI |
| Q16543 | Y248 | Sugiyama | CDC37 CDC37A | VDPRACFRQFFTKIKtADRQyMEGFNDELEAFKERVRGRAK |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16719 | Y86 | Sugiyama | KYNU | ENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVGK |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q6PEY2 | T223 | Sugiyama | TUBA3E | MVDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLR |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | T223 | Sugiyama | TUBA1A TUBA3 | MVDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLR |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | S474 | Sugiyama | SND1 TDRD11 | LVSKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLH |
| Q7KZF4 | S727 | Sugiyama | SND1 TDRD11 | LEKLMENMRNDIAsHPPVEGsyAPRRGEFCIAKFVDGEWYR |
| Q7Z4V5 | Y18 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | ___MPHAFKPGDLVFAKMKGyPHWPARIDDIADGAVKPPPN |
| Q86U86 | S267 | Sugiyama | PBRM1 BAF180 PB1 | AMAKDIDLLAKNAKTYNEPGsQVFKDANSIKKIFYMKKAEI |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8NBJ7 | S264 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | AAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPDsAsD |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8WUM4 | Y223 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | ATRDKMKDAIIAKLANQAADyFGDAFKQCQYKDTLPKEVFP |
| Q92526 | S246 | Sugiyama | CCT6B | EDAFILICNVSLEYEKTEVNsGFFyKTAEEKEKLVKAERKF |
| Q92769 | S89 | Sugiyama | HDAC2 | HSDEYIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDGLFE |
| Q92878 | Y1081 | Sugiyama | RAD50 | EENIDNIKRNHNLALGRQKGyEEEIIHFKKELREPQFRDAE |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q96AE4 | S52 | Sugiyama | FUBP1 | KDALQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQ |
| Q96AE4 | S55 | Sugiyama | FUBP1 | LQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDA |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96C19 | T84 | Sugiyama | EFHD2 SWS1 | DLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQy |
| Q96C19 | Y83 | Sugiyama | EFHD2 SWS1 | ADLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQ |
| Q96MG8 | Y350 | Sugiyama | PCMTD1 | PQNLLREKIMKLPLPESLKAyLTYFRDK_____________ |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99426 | Y133 | Sugiyama | TBCB CG22 CKAP1 | AyDQRQDtVRSFLKRsKLGRyNEEERAQQEAEAAQRLAEEK |
| Q99459 | Y788 | Sugiyama | CDC5L KIAA0432 PCDC5RP | ECLKEDVQRQQEREKELQHRyADLLLEKETLKSKF______ |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99613 | Y148 | Sugiyama | EIF3C EIF3S8 | KKMNKNNAKALSTLRQKIRKyNRDFEsHItSyKQNPEQsAD |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q9BQE3 | T223 | Sugiyama | TUBA1C TUBA6 | MVDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLR |
| Q9BQE3 | Y449 | Sugiyama | TUBA1C TUBA6 | EKDyEEVGADsADGEDEGEEy____________________ |
| Q9BRA2 | S41 | Sugiyama | TXNDC17 TXNL5 | QHNGKTIFAyFTGSKDAGGKsWCPDCVQAEPVVREGLKHIS |
| Q9BT78 | S297 | Sugiyama | COPS4 CSN4 | QLQEFAAMLMPHQKATTADGssILDRAVIEHNLLSASKLYN |
| Q9BT78 | S298 | Sugiyama | COPS4 CSN4 | LQEFAAMLMPHQKATTADGssILDRAVIEHNLLSASKLYNN |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9HB71 | T167 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | TDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEtDP |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NSK0 | Y474 | Sugiyama | KLC4 KNSL8 | KACKVssPTVNTTLRNLGALyRRQGKLEAAETLEECALRSR |
| Q9NW13 | Y737 | Sugiyama | RBM28 | SRKKAKGNKTETRFNQLVEQyKQKLLGPSKGAPLAKRSKWF |
| Q9NY65 | T223 | Sugiyama | TUBA8 TUBAL2 | MVDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLR |
| Q9NYU2 | Y1516 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | PMTKEPKLEAAVRIVPEWQDyDQEIKQLQIRFQKEKETGAL |
| Q9UBQ5 | Y21 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | MAMFEQMRANVGKLLKGIDRyNPENLAtLERYVETQAKENA |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UHX1 | Y269 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | FGKIKSCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNL |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UKS6 | Y53 | Sugiyama | PACSIN3 | HRLCGDLVSCFQERARIEKAyAQQLADWARKWRGTVEKGPQ |
| Q9Y281 | S3 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CFL2 | __________________MAsGVtVNDEVIKVFNDMKVRKs |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2G5 | Y228 | Sugiyama | POFUT2 C21orf80 FUT13 KIAA0958 | RNTSARSVMLDRAENLLHDHyGGKEYWDTRRSMVFARHLRE |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y3B8 | Y210 | Sugiyama | REXO2 SFN SMFN CGI-114 | KAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKKRKIIENG |
| Q9Y3E1 | Y22 | Sugiyama | HDGFL3 HDGF2 HDGFRP3 CGI-142 | ARPRPREYKAGDLVFAKMKGyPHWPARIDELPEGAVKPPAN |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y5M8 | S257 | Sugiyama | SRPRB PSEC0230 | LPLKVEFLECSAKGGRGDVGsADIQDLEKWLAKIA______ |
| Q9Y696 | S226 | Sugiyama | CLIC4 | RNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEIAysD |
| Q9Y6E0 | Y295 | Sugiyama | STK24 MST3 STK3 | PTAKELLKHKFILRNAKKTsyLtELIDRYKRWKAEQSHDDS |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by ALK in cancer | R-HSA-9700206 | 5.321465e-10 | 9.274 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.321465e-10 | 9.274 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.117839e-08 | 7.148 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.140773e-07 | 6.669 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.009649e-06 | 5.996 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.394933e-06 | 5.621 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.249425e-05 | 4.034 | 1 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.937816e-04 | 3.713 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.458041e-04 | 3.836 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.602250e-04 | 3.585 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.602250e-04 | 3.585 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.121821e-04 | 3.673 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.515637e-04 | 3.454 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.983994e-04 | 3.400 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.467029e-04 | 3.189 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.124406e-03 | 2.949 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.437710e-03 | 2.842 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.847254e-03 | 2.733 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 2.497291e-03 | 2.603 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.927709e-03 | 2.533 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.832076e-03 | 2.316 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.004727e-03 | 2.222 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.001761e-03 | 2.222 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.369788e-03 | 2.196 | 0 | 0 |
| Drug resistance of ALK mutants | R-HSA-9700649 | 1.031747e-02 | 1.986 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.031747e-02 | 1.986 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.031747e-02 | 1.986 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.031747e-02 | 1.986 | 0 | 0 |
| brigatinib-resistant ALK mutants | R-HSA-9717319 | 1.031747e-02 | 1.986 | 0 | 0 |
| ASP-3026-resistant ALK mutants | R-HSA-9717264 | 1.031747e-02 | 1.986 | 0 | 0 |
| crizotinib-resistant ALK mutants | R-HSA-9717326 | 1.031747e-02 | 1.986 | 0 | 0 |
| NVP-TAE684-resistant ALK mutants | R-HSA-9717301 | 1.031747e-02 | 1.986 | 0 | 0 |
| ceritinib-resistant ALK mutants | R-HSA-9717323 | 1.031747e-02 | 1.986 | 0 | 0 |
| alectinib-resistant ALK mutants | R-HSA-9717316 | 1.031747e-02 | 1.986 | 0 | 0 |
| lorlatinib-resistant ALK mutants | R-HSA-9717329 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.031747e-02 | 1.986 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.031747e-02 | 1.986 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.094421e-03 | 2.149 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.513833e-03 | 2.124 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.227618e-02 | 1.911 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.156575e-02 | 1.937 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.227618e-02 | 1.911 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.266147e-02 | 1.898 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.532914e-02 | 1.814 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.376558e-02 | 1.861 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.592207e-02 | 1.798 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.597063e-02 | 1.797 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.594316e-02 | 1.797 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.497708e-02 | 1.825 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.464033e-02 | 1.834 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.696517e-02 | 1.770 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.696517e-02 | 1.770 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.696517e-02 | 1.770 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.796618e-02 | 1.746 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.822092e-02 | 1.739 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.848197e-02 | 1.733 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.913347e-02 | 1.718 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.006648e-02 | 1.698 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.044813e-02 | 1.689 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.102421e-02 | 1.677 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.420163e-02 | 1.616 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.444926e-02 | 1.612 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.404579e-02 | 1.619 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.420163e-02 | 1.616 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.585910e-02 | 1.587 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.420163e-02 | 1.616 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.420163e-02 | 1.616 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.475557e-02 | 1.606 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.617593e-02 | 1.582 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.063602e-02 | 1.514 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.063925e-02 | 1.391 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.063925e-02 | 1.391 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 4.063925e-02 | 1.391 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.063925e-02 | 1.391 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.063925e-02 | 1.391 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.063925e-02 | 1.391 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.020042e-02 | 1.520 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.821323e-02 | 1.550 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.468833e-02 | 1.460 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.813696e-02 | 1.419 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.696294e-02 | 1.432 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.468833e-02 | 1.460 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.063925e-02 | 1.391 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.468833e-02 | 1.460 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.444176e-02 | 1.463 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.909449e-02 | 1.536 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.075562e-02 | 1.512 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.907630e-02 | 1.408 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.696294e-02 | 1.432 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.471966e-02 | 1.459 | 1 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.150147e-02 | 1.502 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.835627e-02 | 1.547 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.440282e-02 | 1.463 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.031204e-02 | 1.518 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.297558e-02 | 1.482 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.049219e-02 | 1.393 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.106947e-02 | 1.386 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.626303e-02 | 1.335 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.660540e-02 | 1.332 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.660540e-02 | 1.332 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 4.660540e-02 | 1.332 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.706517e-02 | 1.327 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.053987e-02 | 1.296 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.053987e-02 | 1.296 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.053987e-02 | 1.296 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.914529e-02 | 1.309 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.437111e-02 | 1.265 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.173429e-02 | 1.286 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.437111e-02 | 1.265 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 5.548558e-02 | 1.256 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.705451e-02 | 1.244 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.055601e-02 | 1.296 | 1 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.651272e-02 | 1.248 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.437111e-02 | 1.265 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.772004e-02 | 1.239 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 6.033892e-02 | 1.219 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 6.033892e-02 | 1.219 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.033892e-02 | 1.219 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 6.033892e-02 | 1.219 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 6.033892e-02 | 1.219 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 6.033892e-02 | 1.219 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.003744e-02 | 1.155 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.963645e-02 | 1.099 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.963645e-02 | 1.099 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.963645e-02 | 1.099 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 8.913696e-02 | 1.050 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.853999e-02 | 1.006 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.078465e-01 | 0.967 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.078465e-01 | 0.967 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.170575e-01 | 0.932 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.170575e-01 | 0.932 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.261740e-01 | 0.899 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.261740e-01 | 0.899 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.441273e-01 | 0.841 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.822964e-02 | 1.166 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.112790e-02 | 1.148 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.204850e-01 | 0.657 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.246083e-02 | 1.034 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.285396e-01 | 0.641 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.285396e-01 | 0.641 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.522103e-01 | 0.598 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.675882e-01 | 0.573 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.751588e-01 | 0.560 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.756670e-01 | 0.755 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.549615e-01 | 0.594 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.549615e-01 | 0.594 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.041243e-01 | 0.690 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.046422e-01 | 0.516 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.257642e-01 | 0.900 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.261740e-01 | 0.899 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.529659e-01 | 0.815 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.021057e-01 | 0.991 | 1 | 1 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.406567e-02 | 1.130 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.704183e-02 | 1.113 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.900676e-01 | 0.538 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.065417e-02 | 1.043 | 1 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.246083e-02 | 1.034 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.086831e-01 | 0.964 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.086831e-01 | 0.964 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.086831e-01 | 0.964 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 1.072181e-01 | 0.970 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.617138e-01 | 0.791 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.675882e-01 | 0.573 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.078465e-01 | 0.967 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.365114e-01 | 0.626 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.617138e-01 | 0.791 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.511374e-01 | 0.600 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.153699e-01 | 0.938 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 1.617138e-01 | 0.791 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.255616e-02 | 1.204 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.250613e-02 | 1.034 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.704183e-02 | 1.113 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.310496e-02 | 1.080 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.900676e-01 | 0.538 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.086831e-01 | 0.964 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.444014e-01 | 0.612 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 1.255893e-01 | 0.901 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.585914e-02 | 1.018 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.180771e-01 | 0.661 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 6.104254e-02 | 1.214 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.046715e-01 | 0.516 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.179752e-02 | 1.087 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.179752e-02 | 1.087 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.179752e-02 | 1.087 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.078465e-01 | 0.967 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.170575e-01 | 0.932 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.529659e-01 | 0.815 | 0 | 0 |
| Acetylation | R-HSA-156582 | 1.529659e-01 | 0.815 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.958164e-01 | 0.708 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.930876e-02 | 1.049 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.246083e-02 | 1.034 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.290427e-01 | 0.889 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.900676e-01 | 0.538 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.267343e-02 | 1.033 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 1.683178e-01 | 0.774 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.017518e-01 | 0.695 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.326113e-02 | 1.080 | 1 | 1 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.123469e-01 | 0.673 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.053803e-01 | 0.977 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.894090e-02 | 1.103 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.853999e-02 | 1.006 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 9.853999e-02 | 1.006 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.261740e-01 | 0.899 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.261740e-01 | 0.899 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.246083e-02 | 1.034 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.246083e-02 | 1.034 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.221587e-01 | 0.913 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.974073e-01 | 0.527 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.927231e-01 | 0.534 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.021057e-01 | 0.991 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.390358e-01 | 0.857 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.018097e-01 | 0.992 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 7.963645e-02 | 1.099 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.078465e-01 | 0.967 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 1.078465e-01 | 0.967 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 1.078465e-01 | 0.967 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.170575e-01 | 0.932 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.351970e-01 | 0.869 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.618980e-02 | 1.065 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.675882e-01 | 0.573 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.751588e-01 | 0.560 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.117408e-01 | 0.952 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.549615e-01 | 0.594 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.675882e-01 | 0.573 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.008328e-01 | 0.522 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.046715e-01 | 0.516 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.444014e-01 | 0.612 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.055161e-01 | 0.687 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.529659e-01 | 0.815 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.898706e-02 | 1.161 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.003744e-02 | 1.155 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 7.963645e-02 | 1.099 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 8.913696e-02 | 1.050 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.261740e-01 | 0.899 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 1.351970e-01 | 0.869 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.529659e-01 | 0.815 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.529659e-01 | 0.815 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.874223e-01 | 0.727 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 2.041243e-01 | 0.690 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.675882e-01 | 0.573 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.751588e-01 | 0.560 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.863231e-01 | 0.730 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.021057e-01 | 0.991 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.618980e-02 | 1.065 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.244421e-01 | 0.649 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.913696e-02 | 1.050 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.703719e-01 | 0.769 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 1.703719e-01 | 0.769 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.958164e-01 | 0.708 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.041243e-01 | 0.690 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.930876e-02 | 1.049 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.187520e-01 | 0.925 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.751588e-01 | 0.560 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.900676e-01 | 0.538 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.123469e-01 | 0.673 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.285396e-01 | 0.641 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.053803e-01 | 0.977 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.053803e-01 | 0.977 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.480881e-01 | 0.605 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.204850e-01 | 0.657 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.610241e-01 | 0.793 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.759109e-01 | 0.559 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.001961e-01 | 0.999 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.170575e-01 | 0.932 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 1.703719e-01 | 0.769 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.041243e-01 | 0.690 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.522103e-01 | 0.598 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.320515e-01 | 0.634 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.930876e-02 | 1.049 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.741405e-01 | 0.759 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 2.434914e-01 | 0.614 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.351970e-01 | 0.869 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 1.958164e-01 | 0.708 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.430697e-01 | 0.844 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 2.826517e-01 | 0.549 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.900676e-01 | 0.538 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.859461e-02 | 1.006 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.285396e-01 | 0.641 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.972912e-02 | 1.157 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.522103e-01 | 0.598 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.942487e-01 | 0.712 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.994070e-01 | 0.700 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.706265e-02 | 1.060 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.170575e-01 | 0.932 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.703719e-01 | 0.769 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.703719e-01 | 0.769 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 2.365114e-01 | 0.626 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.740927e-01 | 0.562 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.358625e-01 | 0.627 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.001289e-01 | 0.699 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.216246e-01 | 0.654 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.170575e-01 | 0.932 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.529659e-01 | 0.815 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.041243e-01 | 0.690 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.041243e-01 | 0.690 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.123469e-01 | 0.673 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.826517e-01 | 0.549 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.979958e-01 | 0.703 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.444014e-01 | 0.612 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.735287e-01 | 0.563 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.170575e-01 | 0.932 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.529659e-01 | 0.815 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.703719e-01 | 0.769 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.041243e-01 | 0.690 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.041243e-01 | 0.690 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.365114e-01 | 0.626 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 2.599389e-01 | 0.585 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.675882e-01 | 0.573 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.092880e-01 | 0.679 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.564500e-02 | 1.019 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.826517e-01 | 0.549 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 2.522103e-01 | 0.598 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.646637e-01 | 0.783 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.683178e-01 | 0.774 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.365114e-01 | 0.626 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.365114e-01 | 0.626 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.406567e-02 | 1.130 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.675882e-01 | 0.573 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.046715e-01 | 0.516 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.541513e-01 | 0.812 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.748464e-02 | 1.111 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.789410e-01 | 0.747 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.310496e-02 | 1.080 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.751588e-01 | 0.560 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.751588e-01 | 0.560 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.511374e-01 | 0.600 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.522103e-01 | 0.598 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.363581e-01 | 0.626 | 1 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.116577e-01 | 0.952 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.244421e-01 | 0.649 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.776696e-01 | 0.556 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.967723e-01 | 0.706 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.430697e-01 | 0.844 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.826517e-01 | 0.549 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.046715e-01 | 0.516 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.055161e-01 | 0.687 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.320515e-01 | 0.634 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 1.537915e-01 | 0.813 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.221587e-01 | 0.913 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 2.900676e-01 | 0.538 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 1.830665e-01 | 0.737 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.535002e-01 | 0.814 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.401965e-01 | 0.853 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.401965e-01 | 0.853 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.900676e-01 | 0.538 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.041243e-01 | 0.690 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.549227e-01 | 0.594 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.351970e-01 | 0.869 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.617138e-01 | 0.791 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 1.573998e-01 | 0.803 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.041243e-01 | 0.690 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.433619e-02 | 1.074 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.845603e-01 | 0.546 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.523694e-01 | 0.817 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.854849e-01 | 0.732 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.703719e-01 | 0.769 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.986819e-01 | 0.702 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.204850e-01 | 0.657 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.348074e-01 | 0.629 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.756670e-01 | 0.755 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.629723e-02 | 1.064 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.084480e-01 | 0.511 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.118611e-01 | 0.506 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.118611e-01 | 0.506 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.148704e-01 | 0.502 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.160470e-01 | 0.500 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.189767e-01 | 0.496 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.189767e-01 | 0.496 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.189767e-01 | 0.496 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.198398e-01 | 0.495 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.198398e-01 | 0.495 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.198398e-01 | 0.495 | 0 | 0 |
| Translation | R-HSA-72766 | 3.249651e-01 | 0.488 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.252361e-01 | 0.488 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.260193e-01 | 0.487 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.260193e-01 | 0.487 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.263557e-01 | 0.486 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.274100e-01 | 0.485 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.329894e-01 | 0.478 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.349580e-01 | 0.475 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.387230e-01 | 0.470 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.398879e-01 | 0.469 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.398879e-01 | 0.469 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.398879e-01 | 0.469 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 3.398879e-01 | 0.469 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 3.403973e-01 | 0.468 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.467155e-01 | 0.460 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.467155e-01 | 0.460 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.467155e-01 | 0.460 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.467155e-01 | 0.460 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.467155e-01 | 0.460 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.467155e-01 | 0.460 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.491473e-01 | 0.457 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.499785e-01 | 0.456 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.499785e-01 | 0.456 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.534728e-01 | 0.452 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.534728e-01 | 0.452 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.534728e-01 | 0.452 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.534728e-01 | 0.452 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.534728e-01 | 0.452 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.534728e-01 | 0.452 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.574467e-01 | 0.447 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.575996e-01 | 0.447 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.601607e-01 | 0.444 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.601607e-01 | 0.444 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.601607e-01 | 0.444 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.632268e-01 | 0.440 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.667798e-01 | 0.436 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.667798e-01 | 0.436 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.667798e-01 | 0.436 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.667798e-01 | 0.436 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 3.667798e-01 | 0.436 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.733308e-01 | 0.428 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.759789e-01 | 0.425 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.798145e-01 | 0.420 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 3.798145e-01 | 0.420 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.798145e-01 | 0.420 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.802392e-01 | 0.420 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.802392e-01 | 0.420 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.833316e-01 | 0.416 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.862315e-01 | 0.413 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.862315e-01 | 0.413 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.862315e-01 | 0.413 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 3.869942e-01 | 0.412 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.869942e-01 | 0.412 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.893521e-01 | 0.410 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.925825e-01 | 0.406 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.925825e-01 | 0.406 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.925825e-01 | 0.406 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.925825e-01 | 0.406 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.929644e-01 | 0.406 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.942910e-01 | 0.404 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.967998e-01 | 0.401 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.988681e-01 | 0.399 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.988681e-01 | 0.399 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.015485e-01 | 0.396 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.050891e-01 | 0.392 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 4.050891e-01 | 0.392 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.087653e-01 | 0.389 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.087653e-01 | 0.389 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.112461e-01 | 0.386 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.112461e-01 | 0.386 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.112461e-01 | 0.386 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.159400e-01 | 0.381 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.173397e-01 | 0.380 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.173397e-01 | 0.380 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.173397e-01 | 0.380 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.173397e-01 | 0.380 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.173397e-01 | 0.380 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.173397e-01 | 0.380 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.195112e-01 | 0.377 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.233707e-01 | 0.373 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.233707e-01 | 0.373 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.233707e-01 | 0.373 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.233707e-01 | 0.373 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.293396e-01 | 0.367 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.293396e-01 | 0.367 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.293396e-01 | 0.367 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.293396e-01 | 0.367 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.293396e-01 | 0.367 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.336841e-01 | 0.363 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.352471e-01 | 0.361 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.410937e-01 | 0.355 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.410937e-01 | 0.355 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.435042e-01 | 0.353 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.462107e-01 | 0.350 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.468803e-01 | 0.350 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.468803e-01 | 0.350 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.468803e-01 | 0.350 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.468803e-01 | 0.350 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.468803e-01 | 0.350 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 4.489121e-01 | 0.348 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.526072e-01 | 0.344 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.526072e-01 | 0.344 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.526072e-01 | 0.344 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.580353e-01 | 0.339 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.582752e-01 | 0.339 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.582752e-01 | 0.339 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.638849e-01 | 0.334 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.638849e-01 | 0.334 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.638849e-01 | 0.334 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.638849e-01 | 0.334 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.638849e-01 | 0.334 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.694368e-01 | 0.328 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.694368e-01 | 0.328 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.694368e-01 | 0.328 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.694368e-01 | 0.328 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.694368e-01 | 0.328 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.716785e-01 | 0.326 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.749316e-01 | 0.323 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.749316e-01 | 0.323 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.749316e-01 | 0.323 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 4.749316e-01 | 0.323 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.756252e-01 | 0.323 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.784232e-01 | 0.320 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.803698e-01 | 0.318 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.803698e-01 | 0.318 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.803698e-01 | 0.318 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 4.803698e-01 | 0.318 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.803698e-01 | 0.318 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.817759e-01 | 0.317 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.857520e-01 | 0.314 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.857520e-01 | 0.314 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.857520e-01 | 0.314 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.857520e-01 | 0.314 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.857520e-01 | 0.314 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.857520e-01 | 0.314 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.857520e-01 | 0.314 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.910788e-01 | 0.309 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.910788e-01 | 0.309 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.913691e-01 | 0.309 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.950544e-01 | 0.305 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.963508e-01 | 0.304 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.963508e-01 | 0.304 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.963508e-01 | 0.304 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.983404e-01 | 0.302 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 5.015684e-01 | 0.300 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.015684e-01 | 0.300 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.015684e-01 | 0.300 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.067324e-01 | 0.295 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.067324e-01 | 0.295 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.067324e-01 | 0.295 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.067324e-01 | 0.295 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.081169e-01 | 0.294 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.113482e-01 | 0.291 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.118431e-01 | 0.291 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.118431e-01 | 0.291 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.118431e-01 | 0.291 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.118431e-01 | 0.291 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.145657e-01 | 0.289 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.169012e-01 | 0.287 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.169012e-01 | 0.287 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.169012e-01 | 0.287 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.219072e-01 | 0.282 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.219072e-01 | 0.282 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.219072e-01 | 0.282 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.268617e-01 | 0.278 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.268617e-01 | 0.278 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.268617e-01 | 0.278 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.296851e-01 | 0.276 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.304437e-01 | 0.275 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.314418e-01 | 0.275 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.317651e-01 | 0.274 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.339339e-01 | 0.273 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.366179e-01 | 0.270 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.461742e-01 | 0.263 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.520773e-01 | 0.258 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.555346e-01 | 0.255 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.555346e-01 | 0.255 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.555346e-01 | 0.255 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.555346e-01 | 0.255 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.601426e-01 | 0.252 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.601426e-01 | 0.252 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.601426e-01 | 0.252 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.601426e-01 | 0.252 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.601426e-01 | 0.252 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.647030e-01 | 0.248 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.647030e-01 | 0.248 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.692165e-01 | 0.245 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.692165e-01 | 0.245 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 5.692165e-01 | 0.245 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.714922e-01 | 0.243 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.736835e-01 | 0.241 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.736835e-01 | 0.241 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.781044e-01 | 0.238 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.781044e-01 | 0.238 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.824797e-01 | 0.235 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.824797e-01 | 0.235 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.824797e-01 | 0.235 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.846430e-01 | 0.233 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.903744e-01 | 0.229 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.910955e-01 | 0.228 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 5.910955e-01 | 0.228 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.910955e-01 | 0.228 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.910955e-01 | 0.228 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.953369e-01 | 0.225 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.988618e-01 | 0.223 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.995345e-01 | 0.222 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.995345e-01 | 0.222 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.036889e-01 | 0.219 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.078005e-01 | 0.216 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.118696e-01 | 0.213 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.158967e-01 | 0.210 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.158967e-01 | 0.210 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.277307e-01 | 0.202 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.277307e-01 | 0.202 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 6.288555e-01 | 0.201 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.341192e-01 | 0.198 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.354180e-01 | 0.197 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.354180e-01 | 0.197 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.364054e-01 | 0.196 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.392022e-01 | 0.194 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.427528e-01 | 0.192 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 6.429474e-01 | 0.192 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.466539e-01 | 0.189 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.466539e-01 | 0.189 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.470246e-01 | 0.189 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.503222e-01 | 0.187 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 6.505906e-01 | 0.187 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.539527e-01 | 0.184 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.539527e-01 | 0.184 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.575457e-01 | 0.182 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.611015e-01 | 0.180 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.646207e-01 | 0.177 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.681036e-01 | 0.175 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.681036e-01 | 0.175 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.693482e-01 | 0.174 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.715505e-01 | 0.173 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.715505e-01 | 0.173 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.715505e-01 | 0.173 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.715505e-01 | 0.173 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.749618e-01 | 0.171 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.783379e-01 | 0.169 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.783379e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.783379e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.783379e-01 | 0.169 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.812530e-01 | 0.167 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.849859e-01 | 0.164 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.882585e-01 | 0.162 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.882585e-01 | 0.162 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.914973e-01 | 0.160 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.947026e-01 | 0.158 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 6.950813e-01 | 0.158 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.978748e-01 | 0.156 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.978748e-01 | 0.156 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.978748e-01 | 0.156 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.041214e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.041214e-01 | 0.152 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.071963e-01 | 0.150 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.071963e-01 | 0.150 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.132512e-01 | 0.147 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.132512e-01 | 0.147 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.132512e-01 | 0.147 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.132512e-01 | 0.147 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.162318e-01 | 0.145 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.162318e-01 | 0.145 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.191817e-01 | 0.143 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.191817e-01 | 0.143 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.221121e-01 | 0.141 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.249902e-01 | 0.140 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.249902e-01 | 0.140 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.249902e-01 | 0.140 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.278495e-01 | 0.138 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.278495e-01 | 0.138 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.301217e-01 | 0.137 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.362513e-01 | 0.133 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.376306e-01 | 0.132 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.417088e-01 | 0.130 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.417088e-01 | 0.130 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.443952e-01 | 0.128 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.443952e-01 | 0.128 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.496852e-01 | 0.125 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.496852e-01 | 0.125 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 7.512899e-01 | 0.124 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.574167e-01 | 0.121 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.574167e-01 | 0.121 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 7.599408e-01 | 0.119 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.599408e-01 | 0.119 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.661518e-01 | 0.116 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.673573e-01 | 0.115 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.714340e-01 | 0.113 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.721747e-01 | 0.112 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.837888e-01 | 0.106 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 7.837888e-01 | 0.106 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.860400e-01 | 0.105 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.860400e-01 | 0.105 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.899836e-01 | 0.102 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.907053e-01 | 0.102 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.032306e-01 | 0.095 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.073092e-01 | 0.093 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 8.107568e-01 | 0.091 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.132700e-01 | 0.090 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.152160e-01 | 0.089 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.228002e-01 | 0.085 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.246474e-01 | 0.084 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.300749e-01 | 0.081 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.318467e-01 | 0.080 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.353354e-01 | 0.078 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.353354e-01 | 0.078 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.370527e-01 | 0.077 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.387522e-01 | 0.076 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.404340e-01 | 0.075 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.437456e-01 | 0.074 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.501652e-01 | 0.070 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.548072e-01 | 0.068 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.622283e-01 | 0.064 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.650900e-01 | 0.063 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.678927e-01 | 0.062 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.733255e-01 | 0.059 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.746487e-01 | 0.058 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.796128e-01 | 0.056 | 1 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.809624e-01 | 0.055 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.824882e-01 | 0.054 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.883270e-01 | 0.051 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 8.906495e-01 | 0.050 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.984067e-01 | 0.047 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.015613e-01 | 0.045 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.126269e-01 | 0.040 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.193861e-01 | 0.037 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.235325e-01 | 0.035 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.266873e-01 | 0.033 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.307903e-01 | 0.031 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.319000e-01 | 0.031 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.381569e-01 | 0.028 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.420753e-01 | 0.026 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.436733e-01 | 0.025 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.457370e-01 | 0.024 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.480620e-01 | 0.023 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.540239e-01 | 0.020 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.594777e-01 | 0.018 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.638649e-01 | 0.016 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.716693e-01 | 0.012 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.725556e-01 | 0.012 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.725556e-01 | 0.012 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.728449e-01 | 0.012 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.746379e-01 | 0.011 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.779963e-01 | 0.010 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.802493e-01 | 0.009 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.814655e-01 | 0.008 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.820469e-01 | 0.008 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.822366e-01 | 0.008 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.862428e-01 | 0.006 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.866696e-01 | 0.006 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.904874e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.908593e-01 | 0.004 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.950240e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.971238e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999809e-01 | 0.000 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.000000e+00 | 0.000 | 1 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.000000e+00 | 0.000 | 1 | 1 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.776357e-15 | 14.750 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.772360e-15 | 14.169 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.976197e-14 | 13.704 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.278977e-13 | 12.893 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.088330e-13 | 12.680 | 1 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.742562e-13 | 12.427 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.825340e-13 | 12.235 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.483369e-12 | 11.829 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.775224e-12 | 11.557 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.736700e-12 | 11.563 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.332801e-12 | 11.135 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.093947e-11 | 10.961 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.365474e-11 | 10.865 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.052036e-11 | 10.688 | 1 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.716183e-11 | 10.430 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.716183e-11 | 10.430 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.502876e-11 | 10.347 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.226930e-11 | 10.206 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.878953e-11 | 10.162 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.338874e-11 | 10.134 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.850920e-11 | 10.105 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.565071e-11 | 10.019 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.092202e-10 | 9.962 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.439472e-10 | 9.842 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.621410e-10 | 9.790 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.123983e-10 | 9.673 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.567785e-10 | 9.448 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.567785e-10 | 9.448 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.814112e-10 | 9.419 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.814112e-10 | 9.419 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.642002e-10 | 9.333 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.838036e-10 | 9.234 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.400526e-10 | 9.131 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.400526e-10 | 9.131 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.609020e-10 | 9.065 | 1 | 0 |
| Depurination | R-HSA-73927 | 9.328045e-10 | 9.030 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.168849e-09 | 8.932 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.175324e-09 | 8.930 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.241457e-09 | 8.906 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.262949e-09 | 8.899 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.444027e-09 | 8.840 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.458379e-09 | 8.836 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.458379e-09 | 8.836 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.794564e-09 | 8.746 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.809751e-09 | 8.742 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.809751e-09 | 8.742 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.121609e-09 | 8.673 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.359496e-09 | 8.627 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.747761e-09 | 8.561 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.747761e-09 | 8.561 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.359597e-09 | 8.474 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.363206e-09 | 8.473 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.206960e-09 | 8.494 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.206960e-09 | 8.494 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.618326e-09 | 8.441 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.993247e-09 | 8.399 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.975796e-09 | 8.303 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.975796e-09 | 8.303 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.610840e-09 | 8.251 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.917599e-09 | 8.228 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.917599e-09 | 8.228 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.247087e-09 | 8.140 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.119228e-09 | 8.090 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.119228e-09 | 8.090 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.698003e-09 | 8.061 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 9.054766e-09 | 8.043 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.198287e-09 | 8.036 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.965486e-09 | 8.002 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.002751e-08 | 7.999 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.054805e-08 | 7.977 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.100679e-08 | 7.958 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.292580e-08 | 7.889 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.428247e-08 | 7.845 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.454463e-08 | 7.837 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.626491e-08 | 7.789 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.744694e-08 | 7.758 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.819674e-08 | 7.740 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.908940e-08 | 7.719 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.425040e-08 | 7.615 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.540963e-08 | 7.595 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.622326e-08 | 7.581 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.846654e-08 | 7.546 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.007667e-08 | 7.522 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.862206e-08 | 7.413 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.449976e-08 | 7.352 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.530116e-08 | 7.344 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.044426e-08 | 7.297 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.929329e-08 | 7.307 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.261736e-08 | 7.279 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.220595e-08 | 7.141 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.220595e-08 | 7.141 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.220595e-08 | 7.141 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.434276e-08 | 7.074 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.638426e-08 | 7.016 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.722933e-08 | 7.012 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.073838e-07 | 6.969 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.168426e-07 | 6.932 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.427844e-07 | 6.845 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.444793e-07 | 6.840 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.604867e-07 | 6.795 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.678199e-07 | 6.775 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.731656e-07 | 6.762 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.827676e-07 | 6.738 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.990187e-07 | 6.701 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.357009e-07 | 6.628 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.381241e-07 | 6.623 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.450055e-07 | 6.611 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.669345e-07 | 6.574 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.090073e-07 | 6.510 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.090073e-07 | 6.510 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.456114e-07 | 6.461 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.399575e-07 | 6.469 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.812123e-07 | 6.419 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.812123e-07 | 6.419 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.812123e-07 | 6.419 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.129929e-07 | 6.384 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.493038e-07 | 6.347 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.847497e-07 | 6.314 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.628850e-07 | 6.250 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.745946e-07 | 6.241 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.085657e-07 | 6.216 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.906178e-07 | 6.161 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.594779e-07 | 6.119 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.631963e-07 | 6.117 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.668352e-07 | 6.115 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.117201e-07 | 6.091 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.906189e-07 | 6.050 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.443640e-07 | 6.073 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.443640e-07 | 6.073 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.803126e-07 | 6.009 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.466176e-07 | 6.072 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.991862e-07 | 6.000 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.120441e-06 | 5.951 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.163164e-06 | 5.934 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.163164e-06 | 5.934 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.196971e-06 | 5.922 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.218831e-06 | 5.914 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.291498e-06 | 5.889 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.291498e-06 | 5.889 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.391616e-06 | 5.856 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.526824e-06 | 5.816 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.601722e-06 | 5.795 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.925029e-06 | 5.716 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.055849e-06 | 5.687 | 1 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.335225e-06 | 5.632 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.533486e-06 | 5.596 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.560811e-06 | 5.592 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.567669e-06 | 5.590 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.587792e-06 | 5.587 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.671034e-06 | 5.573 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.698278e-06 | 5.569 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.337981e-06 | 5.477 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.956128e-06 | 5.529 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.094123e-06 | 5.509 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.337981e-06 | 5.477 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.391129e-06 | 5.470 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.888764e-06 | 5.410 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.525906e-06 | 5.344 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.889865e-06 | 5.311 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.033617e-06 | 5.298 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.184430e-06 | 5.209 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 6.455277e-06 | 5.190 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.725878e-06 | 5.112 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.452442e-06 | 5.073 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.022857e-05 | 4.990 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.022857e-05 | 4.990 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.168199e-05 | 4.932 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.325035e-05 | 4.878 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.409749e-05 | 4.851 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.409749e-05 | 4.851 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.516666e-05 | 4.819 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.570451e-05 | 4.804 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.598828e-05 | 4.796 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.765238e-05 | 4.753 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.000193e-05 | 4.699 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.021509e-05 | 4.694 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.093474e-05 | 4.679 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.913162e-05 | 4.536 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.000535e-05 | 4.523 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.146845e-05 | 4.502 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.781984e-05 | 4.422 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.031758e-05 | 4.395 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.427336e-05 | 4.354 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.102670e-05 | 4.292 | 1 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.396913e-05 | 4.357 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.222651e-05 | 4.282 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.272278e-05 | 4.278 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.417858e-05 | 4.266 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.506188e-05 | 4.259 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.563323e-05 | 4.255 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.563323e-05 | 4.255 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.563323e-05 | 4.255 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.727015e-05 | 4.242 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.727015e-05 | 4.242 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.727015e-05 | 4.242 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.727015e-05 | 4.242 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.888236e-05 | 4.230 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.368420e-05 | 4.196 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.492240e-05 | 4.125 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.492240e-05 | 4.125 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.016443e-05 | 4.096 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.483073e-05 | 4.071 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.777219e-05 | 4.057 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.937144e-05 | 4.049 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.957721e-05 | 4.048 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.287610e-05 | 4.032 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.731803e-05 | 4.012 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.932173e-05 | 4.003 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.155481e-04 | 3.937 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.201983e-04 | 3.920 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.343242e-04 | 3.872 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.428765e-04 | 3.845 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.428765e-04 | 3.845 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.481815e-04 | 3.829 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.589511e-04 | 3.799 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.606438e-04 | 3.794 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.725239e-04 | 3.763 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.797543e-04 | 3.745 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.973659e-04 | 3.705 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.973659e-04 | 3.705 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.176860e-04 | 3.662 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.296246e-04 | 3.639 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.406582e-04 | 3.619 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.746369e-04 | 3.561 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.252394e-04 | 3.488 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.567756e-04 | 3.590 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.321647e-04 | 3.479 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.345610e-04 | 3.476 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.345610e-04 | 3.476 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.660598e-04 | 3.436 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.660598e-04 | 3.436 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.660598e-04 | 3.436 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.928968e-04 | 3.406 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.166297e-04 | 3.380 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.167203e-04 | 3.380 | 1 | 1 |
| Protein methylation | R-HSA-8876725 | 4.167203e-04 | 3.380 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.167203e-04 | 3.380 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.002480e-04 | 3.301 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.777138e-04 | 3.238 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.047677e-04 | 3.218 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.738886e-04 | 3.171 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.766750e-04 | 3.170 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.627795e-04 | 3.118 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.846328e-04 | 3.105 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.267312e-04 | 3.083 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.462878e-04 | 3.072 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.462878e-04 | 3.072 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.294273e-04 | 3.032 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.894747e-04 | 3.005 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.904352e-04 | 3.004 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.904352e-04 | 3.004 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.021720e-03 | 2.991 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.085998e-03 | 2.964 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.085998e-03 | 2.964 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.123589e-03 | 2.949 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.162046e-03 | 2.935 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.384458e-03 | 2.859 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.391510e-03 | 2.857 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.436414e-03 | 2.843 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.480300e-03 | 2.830 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.520181e-03 | 2.818 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.560346e-03 | 2.807 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.574057e-03 | 2.803 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.647047e-03 | 2.783 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.690588e-03 | 2.772 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.690963e-03 | 2.772 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.733962e-03 | 2.761 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.851479e-03 | 2.732 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.967753e-03 | 2.706 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.053800e-03 | 2.687 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.144020e-03 | 2.669 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.366439e-03 | 2.626 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.396912e-03 | 2.620 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.480306e-03 | 2.605 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.499069e-03 | 2.602 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.634587e-03 | 2.579 | 1 | 1 |
| Glucose metabolism | R-HSA-70326 | 2.754113e-03 | 2.560 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.121438e-03 | 2.506 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.129821e-03 | 2.504 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.275423e-03 | 2.485 | 0 | 0 |
| Translation | R-HSA-72766 | 3.431053e-03 | 2.465 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.603696e-03 | 2.443 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.732242e-03 | 2.428 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.885199e-03 | 2.411 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.024644e-03 | 2.299 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.121734e-03 | 2.291 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.345807e-03 | 2.272 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.345807e-03 | 2.272 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 5.345807e-03 | 2.272 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.493677e-03 | 2.260 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.501995e-03 | 2.259 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.246934e-03 | 2.204 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.267138e-03 | 2.203 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.629076e-03 | 2.179 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.523253e-03 | 2.124 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.523253e-03 | 2.124 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.485331e-03 | 2.071 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.659677e-03 | 2.177 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.827785e-03 | 2.008 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.104087e-03 | 2.148 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.040861e-03 | 2.152 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.476130e-03 | 2.072 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 9.283472e-03 | 2.032 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.629076e-03 | 2.179 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.838516e-03 | 2.106 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.838516e-03 | 2.106 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.851072e-03 | 2.007 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.028179e-02 | 1.988 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.034050e-02 | 1.985 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.058966e-02 | 1.975 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.061735e-02 | 1.974 | 1 | 1 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.064543e-02 | 1.973 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.161279e-02 | 1.935 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.161279e-02 | 1.935 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.173302e-02 | 1.931 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.178907e-02 | 1.929 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.178907e-02 | 1.929 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.217204e-02 | 1.915 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.224729e-02 | 1.912 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.245912e-02 | 1.905 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.247758e-02 | 1.904 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.277723e-02 | 1.894 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.301694e-02 | 1.885 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.301694e-02 | 1.885 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.315560e-02 | 1.881 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.317597e-02 | 1.880 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.355697e-02 | 1.868 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.417034e-02 | 1.849 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.417034e-02 | 1.849 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.417034e-02 | 1.849 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.451239e-02 | 1.838 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.487412e-02 | 1.828 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.516239e-02 | 1.819 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.577270e-02 | 1.802 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.629834e-02 | 1.788 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.676654e-02 | 1.776 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.676654e-02 | 1.776 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.676654e-02 | 1.776 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.676654e-02 | 1.776 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.694735e-02 | 1.771 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.694735e-02 | 1.771 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.694735e-02 | 1.771 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.694735e-02 | 1.771 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 1.719607e-02 | 1.765 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.719607e-02 | 1.765 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.719607e-02 | 1.765 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.719607e-02 | 1.765 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.760742e-02 | 1.754 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.801181e-02 | 1.744 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.823007e-02 | 1.739 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.828829e-02 | 1.738 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.873010e-02 | 1.727 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.873010e-02 | 1.727 | 1 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.993530e-02 | 1.700 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.993530e-02 | 1.700 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.993530e-02 | 1.700 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.033761e-02 | 1.692 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.062466e-02 | 1.686 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.099477e-02 | 1.678 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.119193e-02 | 1.674 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.167078e-02 | 1.664 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.199606e-02 | 1.658 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.201873e-02 | 1.657 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.201873e-02 | 1.657 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.312589e-02 | 1.636 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.312589e-02 | 1.636 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.312589e-02 | 1.636 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.524092e-02 | 1.598 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.524092e-02 | 1.598 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.565579e-02 | 1.591 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.693054e-02 | 1.570 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.709909e-02 | 1.567 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.887124e-02 | 1.540 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.887124e-02 | 1.540 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.008291e-02 | 1.522 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.030462e-02 | 1.518 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.152706e-02 | 1.501 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.364800e-02 | 1.473 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.383387e-02 | 1.471 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.383387e-02 | 1.471 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.383387e-02 | 1.471 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.383387e-02 | 1.471 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 3.513970e-02 | 1.454 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 3.513970e-02 | 1.454 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.584129e-02 | 1.446 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.645296e-02 | 1.438 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.773396e-02 | 1.423 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.775649e-02 | 1.423 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.775649e-02 | 1.423 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.775649e-02 | 1.423 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.930436e-02 | 1.406 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 4.036860e-02 | 1.394 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.184354e-02 | 1.378 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.285055e-02 | 1.368 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.285055e-02 | 1.368 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.608802e-02 | 1.336 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.692755e-02 | 1.329 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.705358e-02 | 1.327 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.787562e-02 | 1.320 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.914611e-02 | 1.309 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.048310e-02 | 1.297 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.048310e-02 | 1.297 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.048310e-02 | 1.297 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.075298e-02 | 1.295 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 5.224533e-02 | 1.282 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 5.224533e-02 | 1.282 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 5.224533e-02 | 1.282 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 5.224533e-02 | 1.282 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 5.224533e-02 | 1.282 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 5.224533e-02 | 1.282 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.224533e-02 | 1.282 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.254824e-02 | 1.279 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.317634e-02 | 1.274 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.502214e-02 | 1.259 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.502214e-02 | 1.259 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 5.554657e-02 | 1.255 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.592822e-02 | 1.252 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 6.904874e-02 | 1.161 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.017701e-01 | 0.992 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.449178e-02 | 1.128 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.030747e-02 | 1.044 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.013466e-01 | 0.994 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 1.013466e-01 | 0.994 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.040768e-02 | 1.044 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.874671e-02 | 1.231 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.178926e-02 | 1.209 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.098591e-01 | 0.959 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.450653e-02 | 1.190 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.642994e-02 | 1.178 | 1 | 1 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.965755e-02 | 1.099 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.049130e-02 | 1.218 | 1 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.943952e-02 | 1.158 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.578095e-02 | 1.019 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.914273e-02 | 1.228 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.904874e-02 | 1.161 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 8.555524e-02 | 1.068 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 8.555524e-02 | 1.068 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.017701e-01 | 0.992 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.450653e-02 | 1.190 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.450653e-02 | 1.190 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.450653e-02 | 1.190 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.380759e-02 | 1.132 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.026633e-02 | 1.095 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.030747e-02 | 1.044 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 6.904874e-02 | 1.161 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 6.904874e-02 | 1.161 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.017701e-01 | 0.992 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 1.069994e-01 | 0.971 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.380759e-02 | 1.132 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.037370e-01 | 0.984 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.322096e-02 | 1.199 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.046757e-01 | 0.980 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.963401e-02 | 1.157 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 1.120258e-01 | 0.951 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.965755e-02 | 1.099 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.697059e-02 | 1.061 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.449178e-02 | 1.128 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.841136e-02 | 1.007 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.332884e-02 | 1.079 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.965755e-02 | 1.099 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.493125e-02 | 1.071 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.697059e-02 | 1.061 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.515863e-02 | 1.022 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.969871e-02 | 1.224 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.388388e-02 | 1.027 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.578095e-02 | 1.019 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.033282e-02 | 1.219 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.388388e-02 | 1.027 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.176984e-01 | 0.929 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.176984e-01 | 0.929 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.176984e-01 | 0.929 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 1.176984e-01 | 0.929 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.176984e-01 | 0.929 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 1.197786e-01 | 0.922 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.239563e-01 | 0.907 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.303884e-01 | 0.885 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 1.333452e-01 | 0.875 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.333452e-01 | 0.875 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.333452e-01 | 0.875 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 1.333452e-01 | 0.875 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 1.333452e-01 | 0.875 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.333452e-01 | 0.875 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.333452e-01 | 0.875 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.333452e-01 | 0.875 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.337958e-01 | 0.874 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.364077e-01 | 0.865 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.424875e-01 | 0.846 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 1.424875e-01 | 0.846 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.486236e-01 | 0.828 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.487154e-01 | 0.828 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 1.487154e-01 | 0.828 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.487154e-01 | 0.828 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 1.487154e-01 | 0.828 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.487154e-01 | 0.828 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.487154e-01 | 0.828 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 1.487154e-01 | 0.828 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.526325e-01 | 0.816 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.526325e-01 | 0.816 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.548122e-01 | 0.810 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.548122e-01 | 0.810 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.559637e-01 | 0.807 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.563820e-01 | 0.806 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.610494e-01 | 0.793 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.610494e-01 | 0.793 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.638140e-01 | 0.786 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.638140e-01 | 0.786 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 1.638140e-01 | 0.786 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.673318e-01 | 0.776 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.673318e-01 | 0.776 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.702619e-01 | 0.769 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 1.736430e-01 | 0.760 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.736556e-01 | 0.760 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.736556e-01 | 0.760 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.737069e-01 | 0.760 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.765009e-01 | 0.753 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 1.786457e-01 | 0.748 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 1.786457e-01 | 0.748 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.786457e-01 | 0.748 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.786457e-01 | 0.748 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.786457e-01 | 0.748 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.786457e-01 | 0.748 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.786457e-01 | 0.748 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.786457e-01 | 0.748 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.786457e-01 | 0.748 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.800176e-01 | 0.745 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.800176e-01 | 0.745 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.800176e-01 | 0.745 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.824678e-01 | 0.739 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.864142e-01 | 0.730 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.864142e-01 | 0.730 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.882203e-01 | 0.725 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.906765e-01 | 0.720 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.928425e-01 | 0.715 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.928425e-01 | 0.715 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.932153e-01 | 0.714 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.932153e-01 | 0.714 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.932153e-01 | 0.714 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.932153e-01 | 0.714 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.932153e-01 | 0.714 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.932153e-01 | 0.714 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.992992e-01 | 0.700 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.992992e-01 | 0.700 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.992992e-01 | 0.700 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.992992e-01 | 0.700 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.004602e-01 | 0.698 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 2.012047e-01 | 0.696 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.057813e-01 | 0.687 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 2.075273e-01 | 0.683 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.075273e-01 | 0.683 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.075273e-01 | 0.683 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.075273e-01 | 0.683 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.075273e-01 | 0.683 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.122859e-01 | 0.673 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.122859e-01 | 0.673 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.188101e-01 | 0.660 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.188101e-01 | 0.660 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.188101e-01 | 0.660 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.188101e-01 | 0.660 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.215862e-01 | 0.654 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 2.215862e-01 | 0.654 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 2.215862e-01 | 0.654 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 2.215862e-01 | 0.654 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.253514e-01 | 0.647 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.253514e-01 | 0.647 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.253514e-01 | 0.647 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.319069e-01 | 0.635 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.319069e-01 | 0.635 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 2.353966e-01 | 0.628 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.353966e-01 | 0.628 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.353966e-01 | 0.628 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.353966e-01 | 0.628 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 2.353966e-01 | 0.628 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.353966e-01 | 0.628 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.353966e-01 | 0.628 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.353966e-01 | 0.628 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.384742e-01 | 0.623 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.384742e-01 | 0.623 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.450508e-01 | 0.611 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.450508e-01 | 0.611 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.450508e-01 | 0.611 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.450508e-01 | 0.611 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 2.489628e-01 | 0.604 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 2.489628e-01 | 0.604 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.489628e-01 | 0.604 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.489628e-01 | 0.604 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.489628e-01 | 0.604 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.489628e-01 | 0.604 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.489628e-01 | 0.604 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.489628e-01 | 0.604 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.489628e-01 | 0.604 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.590277e-01 | 0.587 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.622891e-01 | 0.581 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.622891e-01 | 0.581 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.622891e-01 | 0.581 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.622891e-01 | 0.581 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.622891e-01 | 0.581 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.648129e-01 | 0.577 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.661204e-01 | 0.575 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.753798e-01 | 0.560 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.753798e-01 | 0.560 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 2.753798e-01 | 0.560 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.753798e-01 | 0.560 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.753798e-01 | 0.560 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 2.853775e-01 | 0.545 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.882390e-01 | 0.540 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.882390e-01 | 0.540 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.882390e-01 | 0.540 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.882390e-01 | 0.540 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 2.882390e-01 | 0.540 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.882390e-01 | 0.540 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 2.882390e-01 | 0.540 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.902111e-01 | 0.537 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.977284e-01 | 0.526 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.008707e-01 | 0.522 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.008707e-01 | 0.522 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.008707e-01 | 0.522 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.008707e-01 | 0.522 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.042906e-01 | 0.517 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.095967e-01 | 0.509 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 3.132791e-01 | 0.504 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 3.132791e-01 | 0.504 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.132791e-01 | 0.504 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 3.132791e-01 | 0.504 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.132791e-01 | 0.504 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.132791e-01 | 0.504 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.132791e-01 | 0.504 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.132791e-01 | 0.504 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.132791e-01 | 0.504 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 3.254679e-01 | 0.487 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 3.254679e-01 | 0.487 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.369023e-01 | 0.472 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.374412e-01 | 0.472 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.374412e-01 | 0.472 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.377087e-01 | 0.471 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.387367e-01 | 0.470 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.433740e-01 | 0.464 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.477742e-01 | 0.459 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.492026e-01 | 0.457 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.492026e-01 | 0.457 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.492026e-01 | 0.457 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.492026e-01 | 0.457 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.492026e-01 | 0.457 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.498254e-01 | 0.456 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.498254e-01 | 0.456 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 3.562553e-01 | 0.448 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.562553e-01 | 0.448 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.562553e-01 | 0.448 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.581316e-01 | 0.446 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.581316e-01 | 0.446 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 3.607560e-01 | 0.443 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.607560e-01 | 0.443 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.607560e-01 | 0.443 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.607560e-01 | 0.443 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.607560e-01 | 0.443 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.607560e-01 | 0.443 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.626624e-01 | 0.440 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 3.721050e-01 | 0.429 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.721050e-01 | 0.429 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.721050e-01 | 0.429 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.832532e-01 | 0.417 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.832532e-01 | 0.417 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 3.832532e-01 | 0.417 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.832532e-01 | 0.417 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.832532e-01 | 0.417 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.832532e-01 | 0.417 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.942041e-01 | 0.404 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.942041e-01 | 0.404 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.942041e-01 | 0.404 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.942041e-01 | 0.404 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 3.943152e-01 | 0.404 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 4.049612e-01 | 0.393 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.049612e-01 | 0.393 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.067780e-01 | 0.391 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.129632e-01 | 0.384 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.129632e-01 | 0.384 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 4.129632e-01 | 0.384 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 4.155280e-01 | 0.381 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.191163e-01 | 0.378 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.259078e-01 | 0.371 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.259078e-01 | 0.371 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.259078e-01 | 0.371 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.259078e-01 | 0.371 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.361038e-01 | 0.360 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.361038e-01 | 0.360 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.361038e-01 | 0.360 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.361038e-01 | 0.360 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.361038e-01 | 0.360 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 4.417487e-01 | 0.355 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.417487e-01 | 0.355 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 4.461194e-01 | 0.351 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.461194e-01 | 0.351 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.461194e-01 | 0.351 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 4.461194e-01 | 0.351 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.516116e-01 | 0.345 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.516116e-01 | 0.345 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.527973e-01 | 0.344 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 4.559577e-01 | 0.341 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.559577e-01 | 0.341 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.559577e-01 | 0.341 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.559577e-01 | 0.341 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.577457e-01 | 0.339 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.582024e-01 | 0.339 | 1 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 4.612283e-01 | 0.336 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.623437e-01 | 0.335 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.656219e-01 | 0.332 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.656219e-01 | 0.332 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.670993e-01 | 0.331 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.670993e-01 | 0.331 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 4.690829e-01 | 0.329 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 4.729322e-01 | 0.325 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.751149e-01 | 0.323 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.751149e-01 | 0.323 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.751149e-01 | 0.323 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.751149e-01 | 0.323 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.751149e-01 | 0.323 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.844399e-01 | 0.315 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.844399e-01 | 0.315 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.844399e-01 | 0.315 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.844399e-01 | 0.315 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.844399e-01 | 0.315 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.844399e-01 | 0.315 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.844399e-01 | 0.315 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.844399e-01 | 0.315 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.844399e-01 | 0.315 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 4.935998e-01 | 0.307 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.935998e-01 | 0.307 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.958744e-01 | 0.305 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.015104e-01 | 0.300 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.015104e-01 | 0.300 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.015104e-01 | 0.300 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.015104e-01 | 0.300 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.025975e-01 | 0.299 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.025975e-01 | 0.299 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.025975e-01 | 0.299 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.025975e-01 | 0.299 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.025975e-01 | 0.299 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.025975e-01 | 0.299 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.025975e-01 | 0.299 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 5.071058e-01 | 0.295 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.071058e-01 | 0.295 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.114359e-01 | 0.291 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.114359e-01 | 0.291 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.114359e-01 | 0.291 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.114359e-01 | 0.291 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.114359e-01 | 0.291 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.160989e-01 | 0.287 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.160989e-01 | 0.287 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 5.201178e-01 | 0.284 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.201178e-01 | 0.284 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.201178e-01 | 0.284 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.201178e-01 | 0.284 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 5.201178e-01 | 0.284 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.286459e-01 | 0.277 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.286459e-01 | 0.277 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.286459e-01 | 0.277 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.290752e-01 | 0.276 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.290880e-01 | 0.276 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.333746e-01 | 0.273 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.333746e-01 | 0.273 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.333746e-01 | 0.273 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 5.370230e-01 | 0.270 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.370230e-01 | 0.270 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.370230e-01 | 0.270 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.398089e-01 | 0.268 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.452517e-01 | 0.263 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.452517e-01 | 0.263 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 5.452517e-01 | 0.263 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.461018e-01 | 0.263 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.533346e-01 | 0.257 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 5.533346e-01 | 0.257 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.533346e-01 | 0.257 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.612744e-01 | 0.251 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.612744e-01 | 0.251 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.612744e-01 | 0.251 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.668587e-01 | 0.247 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.690735e-01 | 0.245 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.690735e-01 | 0.245 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.690735e-01 | 0.245 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.690735e-01 | 0.245 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.690735e-01 | 0.245 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.760316e-01 | 0.240 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.767345e-01 | 0.239 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.790314e-01 | 0.237 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.810338e-01 | 0.236 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.810338e-01 | 0.236 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.830411e-01 | 0.234 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.909080e-01 | 0.228 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.909877e-01 | 0.228 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.957800e-01 | 0.225 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.989125e-01 | 0.223 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.006085e-01 | 0.221 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.060447e-01 | 0.217 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.060447e-01 | 0.217 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.065866e-01 | 0.217 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.104244e-01 | 0.214 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 6.130506e-01 | 0.213 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.130506e-01 | 0.213 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.199322e-01 | 0.208 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.199322e-01 | 0.208 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.199322e-01 | 0.208 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.199322e-01 | 0.208 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.199322e-01 | 0.208 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.333318e-01 | 0.198 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 6.333318e-01 | 0.198 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.398540e-01 | 0.194 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.398540e-01 | 0.194 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.398540e-01 | 0.194 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.462606e-01 | 0.190 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.508654e-01 | 0.187 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 6.525536e-01 | 0.185 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.525536e-01 | 0.185 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.525536e-01 | 0.185 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.525536e-01 | 0.185 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.587351e-01 | 0.181 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.587351e-01 | 0.181 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.587351e-01 | 0.181 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.587351e-01 | 0.181 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.636714e-01 | 0.178 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.648069e-01 | 0.177 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.648069e-01 | 0.177 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.683883e-01 | 0.175 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.683883e-01 | 0.175 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.707711e-01 | 0.173 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 6.719977e-01 | 0.173 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.719977e-01 | 0.173 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.766295e-01 | 0.170 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 6.766295e-01 | 0.170 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.766295e-01 | 0.170 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.801566e-01 | 0.167 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.823840e-01 | 0.166 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.823840e-01 | 0.166 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.823840e-01 | 0.166 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.823840e-01 | 0.166 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.935887e-01 | 0.159 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 6.959781e-01 | 0.157 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.959781e-01 | 0.157 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 6.990424e-01 | 0.155 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.990424e-01 | 0.155 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.990424e-01 | 0.155 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.990424e-01 | 0.155 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.990424e-01 | 0.155 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.043994e-01 | 0.152 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.096613e-01 | 0.149 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.148300e-01 | 0.146 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.148300e-01 | 0.146 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.148300e-01 | 0.146 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 7.199069e-01 | 0.143 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.199069e-01 | 0.143 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 7.248937e-01 | 0.140 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.248937e-01 | 0.140 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.248937e-01 | 0.140 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.393296e-01 | 0.131 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.395955e-01 | 0.131 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.429784e-01 | 0.129 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 7.453126e-01 | 0.128 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.484428e-01 | 0.126 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.530104e-01 | 0.123 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.530104e-01 | 0.123 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.530104e-01 | 0.123 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.530104e-01 | 0.123 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.574098e-01 | 0.121 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 7.574098e-01 | 0.121 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.617311e-01 | 0.118 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.659756e-01 | 0.116 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.659756e-01 | 0.116 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.659756e-01 | 0.116 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.659756e-01 | 0.116 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.687115e-01 | 0.114 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 7.742400e-01 | 0.111 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.782625e-01 | 0.109 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.860944e-01 | 0.105 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.899063e-01 | 0.102 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.936506e-01 | 0.100 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.004251e-01 | 0.097 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.009408e-01 | 0.096 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.031088e-01 | 0.095 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.044890e-01 | 0.094 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.079743e-01 | 0.093 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.135262e-01 | 0.090 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.180628e-01 | 0.087 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.282323e-01 | 0.082 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.282323e-01 | 0.082 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.306973e-01 | 0.081 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 8.372809e-01 | 0.077 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.391980e-01 | 0.076 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.395958e-01 | 0.076 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 8.424572e-01 | 0.074 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.424572e-01 | 0.074 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 8.480282e-01 | 0.072 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.525117e-01 | 0.069 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.534028e-01 | 0.069 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.534028e-01 | 0.069 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.611117e-01 | 0.065 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.635905e-01 | 0.064 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 8.707654e-01 | 0.060 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.775642e-01 | 0.057 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.775642e-01 | 0.057 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.818975e-01 | 0.055 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.821333e-01 | 0.054 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.881125e-01 | 0.052 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.881125e-01 | 0.052 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.920736e-01 | 0.050 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 8.934784e-01 | 0.049 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.048689e-01 | 0.043 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.048689e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.082387e-01 | 0.042 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.136766e-01 | 0.039 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.161519e-01 | 0.038 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.233848e-01 | 0.035 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.287207e-01 | 0.032 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.379088e-01 | 0.028 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.383068e-01 | 0.028 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.409940e-01 | 0.026 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.485427e-01 | 0.023 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.494249e-01 | 0.023 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.494249e-01 | 0.023 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.494249e-01 | 0.023 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.529521e-01 | 0.021 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.554357e-01 | 0.020 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.570184e-01 | 0.019 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.585450e-01 | 0.018 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.641300e-01 | 0.016 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.741050e-01 | 0.011 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.750264e-01 | 0.011 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.770500e-01 | 0.010 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.771893e-01 | 0.010 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.771909e-01 | 0.010 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.816489e-01 | 0.008 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.829331e-01 | 0.007 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.862727e-01 | 0.006 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.889606e-01 | 0.005 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.918951e-01 | 0.004 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.953254e-01 | 0.002 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.953904e-01 | 0.002 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.957145e-01 | 0.002 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.980089e-01 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.993363e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.995728e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.997042e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.998175e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999118e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999374e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999497e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999949e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999975e-01 | 0.000 | 0 | 0 |